USDM has catalogued 47+ validated AI use cases across the life sciences value chain. Each carries a GxP compliance pathway, risk classification, and implementation framework. Filter by domain to explore relevant opportunities.
AI-assisted SOP review, change control analysis, and CAPA drafting using validated LLM pipelines with full audit trail controls.
Intelligent classification of quality events by risk level — routing only high-complexity deviations through intensive investigation cycles.
AI anomaly detection across GxP audit trails — surfacing ALCOA+ violations, backdating patterns, and data integrity risks pre-inspection.
OSINT-powered continuous monitoring of third-party vendors and AI tools — automated risk scoring and audit-ready qualification packages.
AI-augmented adverse event signal detection and case processing — with regulatory-compliant oversight controls and 21 CFR Part 314 alignment.
AI-assisted outlier detection, protocol deviation identification, and site performance monitoring within validated eClinical environments per ICH E6 R3.
GenAI-assisted regulatory document drafting (CSRs, eCTD sections, labeling) with qualified reviewer oversight workflow and audit trail.
AI-powered regulatory change monitoring across 50+ global health authorities — automated impact assessment and compliance framework updates.
AI-driven statistical process control, real-time deviation alerts, and predictive quality analytics for GMP manufacturing environments.
AI-assisted formulation modeling and chemistry, manufacturing, and controls optimization — accelerating development timelines.
ML-powered analysis of genomic, proteomic, and clinical data to accelerate target selection and patient stratification in early research.
Automated scientific literature surveillance, patent monitoring, and competitive landscape intelligence for research and regulatory strategy.
LLM-powered scientific content drafting with MLR workflow integration — maintaining promotional compliance while accelerating medical communications.
Predictive analytics for supply chain disruption detection, demand forecasting, and API inventory optimization across global supplier networks.
AI-powered sales forecasting, patient access analytics, and HCP engagement intelligence — compliant with Sunshine Act and privacy regulations.
Every AI use case is evaluated across three dimensions to determine priority and investment sequencing:
GxP impact, FDA/EU AI Act classification, patient safety proximity, inspection exposure
